Moderna, Inc. (0QF)
XHAN
Closed
Aug 21, 2026
Day's Range
112.0052 wk Range
19.40Overview - 0QF - Moderna, Inc.
Key Statistics
Valuation
Enterprise Value
-1.29B
P/E (Trailing)
‪-17.84‬
PEG Ratio
‪2.37‬
Price / Book
‪7.62‬
EV / EBITDA
‪0.50‬
Profitability
Gross Margin
‪34.96%‬
Profit Margin
‪54.83%‬
Operating Margin
‪-143.49%‬
Return on Assets
‪-22.87%‬
Return on Equity
‪-32.62%‬
Ownership
Shares Outstanding
399.00M
Price stats
50-Day Avg
‪57.79‬
200-Day Avg
‪42.19‬
Peers - 0QF - Moderna, Inc.
Peer Comparison
Compared with companies in Biotechnology listed on XHAN.
- 0QFXHANModerna, Inc.+82.89%52-week change-17.84P/E (Trailing)‪54.83%‬Profit Margin
- BBZAXHANBB Biotech AG+43.03%52-week change5.58P/E (Trailing)—Profit Margin
- 1AEAXHANargenx SE American Depositary Receipt+34.08%52-week change42.46P/E (Trailing)‪89.14%‬Profit Margin
- ANLXHANAnalog Devices, Inc.+32.46%52-week change69.63P/E (Trailing)‪61.46%‬Profit Margin
- BM8XHANBiomarin Pharmaceutical Inc.+14.63%52-week change31.80P/E (Trailing)‪77.72%‬Profit Margin
- ANTHXHANBrw Stable Return Fund-2.88%52-week change—P/E (Trailing)—Profit Margin
- 22UAXHANBioNTech SE-21.70%52-week change—P/E (Trailing)—Profit Margin
Profile Summary - 0QF - Moderna, Inc.
About
Moderna, Inc. is a biotechnology company specializing in the research, development, and provision of messenger RNA (mRNA) medicines in the United States, Europe, and internationally. Its primary function centers on creating innovative therapeutics and vaccines using mRNA technology, targeting a broad spectrum of…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
